Finance

Lists
RYM:NZE
Ryman Healthcare Ltd
NZ$1,71
+1,79%
(+0,030) 1D
9 Okt., 16:59:44 GMT+13  ·   NZD
All symbols
SymbolPriceChange% Change
Generating top insights for RYM...
Open
NZ$1,68
High
NZ$1,73
Low
NZ$1,66
Mkt. cap
1,78 mjd
Avg. vol.
2,61 m
Volume
2,25 m
52-wk high
NZ$3,05
52-wk low
NZ$1,66
EPS
-NZ$0,17
Shares outstanding
1,02 mjd
No. of employees
8 k
Open
NZ$1,68
High
NZ$1,73
Low
NZ$1,66
Mkt. cap
1,78 mjd
Avg. vol.
2,61 m
Volume
2,25 m
52-wk high
NZ$3,05
52-wk low
NZ$1,66
EPS
-NZ$0,17
Shares outstanding
1,02 mjd
No. of employees
8 k
News stories
From web sources and news partners
Profile
Ryman Healthcare Limited is a New Zealand retirement village and rest home operator. It is listed on the New Zealand Stock Exchange and was one of the largest companies listed on the NZX 50 Index. Ryman Healthcare has 48 operational villages across New Zealand and eight in Melbourne, and is developing further villages in New Zealand and Victoria. Its name is a portmanteau of its two founders, John Ryder and Kevin Hickman, who founded the company in 1984. As at June 2024, Ryman Healthcare has a market capitalisation of over $2.6 Billion NZD. Ryman's business model is a mixture of property development and healthcare services. It operates on a "deferred management fees" model where the village resident pays for a lifetime occupancy use of their apartment or unit, and upon moving out, the resident or their estate receives a lesser sum back for their unit, capped at 20% deducted if over a five-year period. Ryman Healthcare villages offer a blend of different retirement living options at their villages, which are usually large enough to support a mini-hospital for residents and a secure dementia wing. Wikipedia
About Ryman Healthcare Ltd
CEO-
Employees7,8 k
Founded1984
Headquarters-
SectorHealth care provider
Websiterymanhealthcare.co.nz
Previous reportsAll values in NZD
Loading Previous Earnings...
Revenue
Net income
All values in NZD
Jun. 2025
Sep. 2025
Des. 2025
Mrt. 2026
Revenue
206,73 m
206,73 m
220,50 m
220,50 m
Cost of goods sold
188,46 m
188,46 m
198,38 m
198,38 m
Cost of revenue
188,46 m
188,46 m
198,38 m
198,38 m
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-
-
-
-
Operating expense
10,91 m
10,91 m
10,37 m
10,37 m
Total operating expenses
199,37 m
199,37 m
208,75 m
208,75 m
Operating income
7,36 m
7,36 m
11,75 m
11,75 m
Other non operating income
-
-
3,63 m
3,63 m
EBT including unusual items
-20,10 m
-20,10 m
-68,71 m
-68,71 m
EBT excluding unusual items
-20,50 m
-20,50 m
-18,06 m
-18,06 m
Income tax expense
2,50 m
2,50 m
-5,63 m
-5,63 m
Effective tax rate
-12,44%
-12,44%
8,20%
8,20%
Other operating expenses
-
-
-
-
Net income
-22,60 m
-22,60 m
-63,08 m
-63,08 m
Net profit margin
-10,93%
-10,93%
-28,61%
-28,61%
Earnings per share
-
-
-
-
Interest and investment income
156,00 k
156,00 k
403,50 k
403,50 k
Interest expense
-28,02 m
-28,02 m
-33,84 m
-33,84 m
Net interest expenses
-27,87 m
-27,87 m
-33,43 m
-33,43 m
Depreciation and amortization charges
10,91 m
10,91 m
10,37 m
10,37 m
EBITDA
18,27 m
18,27 m
20,69 m
20,69 m
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme